Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.755 USD | +3.03% | +9.10% | +2.72% |
Nov. 13 | NGM Biopharmaceuticals Says Phase 2b Trial of Potential Cirrhosis Treatment Meets Primary Endpoint | MT |
Sep. 18 | Alpine 4 Holdings, Inc.(NasdaqCM:ALPP) dropped from S&P Global BMI Index | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+2.72% | 19.8M | |
+4.75% | 32.16B | |
-3.81% | 20.33B | |
+1.28% | 20.14B | |
+9.85% | 15.37B | |
-6.09% | 12.06B | |
+2.93% | 11.12B | |
-7.34% | 9.21B | |
+1.81% | 7.94B | |
+29.55% | 6.89B |
- Stock
- Equities
- Stock Alpine 4 Holdings, Inc. - Nasdaq
- News Alpine 4 Holdings, Inc.
- Sector Update: Tech